Phase II study of neoadjuvant gemcitabine, epirubicin, and albumin-bound nab paclitaxel (GEA) in locally advanced breast cancer with SPARC tumor assessments

Journal article

Peer reviewed

D. A. Yardley, R. C. Inhorn, D. Daniel, B. Daniel, Y. Naot, J. Zubkus, L. Simons, D. Knauer, V. Trieu and N. Desai

Journal of clinical oncology, Vol.26(15_suppl), pp.603-603

20/05/2008

Abstract

Abstract only

1 Record Views

Title: Phase II study of neoadjuvant gemcitabine, epirubicin, and albumin-bound nab paclitaxel (GEA) in locally advanced breast cancer with SPARC tumor assessments
Creators - without role: D. A. Yardley
R. C. Inhorn
D. Daniel
B. Daniel
Y. Naot
J. Zubkus
L. Simons
D. Knauer
V. Trieu
N. Desai
Publication Details: Journal of clinical oncology, Vol.26(15_suppl), pp.603-603
Identifiers: 9944636008331
Academic Unit: King Abdullah University of Science & Technology
Language: English
Resource Type: Journal article